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Abstract
Background: MicroRNAs (miRs) are non-coding RNA molecules involved in post-transcriptional regulation, with 
diverse functions in tissue development, differentiation, cell proliferation and apoptosis. miRs may be less prone to 
degradation during formalin fixation, facilitating miR expression studies in formalin-fixed paraffin-embedded (FFPE) 
tissue.
Results: Our study demonstrates that the TaqMan Human MicroRNA Array v1.0 (Early Access) platform is suitable for 
miR expression analysis in FFPE tissue with a high reproducibility (correlation coefficients of 0.95 between duplicates, p 
< 0.00001) and outlines the optimal performance conditions of this platform using clinical FFPE samples. We also 
outline a method of data analysis looking at differences in miR abundance between FFPE and fresh-frozen samples. By 
dividing the profiled miR into abundance strata of high (Ct<30), medium (30≤Ct≤35), and low (Ct>35), we show that 
reproducibility between technical replicates, equivalent dilutions, and FFPE vs. frozen samples is best in the high 
abundance stratum. We also demonstrate that the miR expression profiles of FFPE samples are comparable to those of 
fresh-frozen samples, with a correlation of up to 0.87 (p < 0.001), when examining all miRs, regardless of RNA extraction 
method used. Examining correlation coefficients between FFPE and fresh-frozen samples in terms of miR abundance 
reveals correlation coefficients of up to 0.32 (low abundance), 0.70 (medium abundance) and up to 0.97 (high 
abundance).
Conclusion: Our study thus demonstrates the utility, reproducibility, and optimization steps needed in miR expression 
studies using FFPE samples on a high-throughput quantitative PCR-based miR platform, opening up a realm of 
research possibilities for retrospective studies.
Background
MicroRNAs (miRs) are small, non-coding RNA mole-
cules of 17-27 nucleotides in length, involved in gene reg-
ulation at the post-transcriptional level [1]. They inhibit
translation by partially or totally binding to the comple-
mentary 3' UTR of their target mRNAs within the multi-
protein RNA-induced silencing complex (RISC). Full
complementarity between a miR and its target mRNA
results in mRNA degradation; partial complementarity
leads to inhibition of mRNA translation. The literature on
miRs has grown exponentially within the past decade as
these small molecules have demonstrated various roles in
early development, cell proliferation, differentiation,
apoptosis and oncogenesis [1-6]. Therefore, techniques to
analyze and characterize their expression are a key to
understanding their role in disease and development.
Anatomical pathology laboratories worldwide contain a
vast stock of samples that can potentially be used for
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analysis of disease states. These are in the form of forma-
lin-fixed, paraffin-embedded (FFPE) samples that are
stored for up to 20 years and possibly longer depending
on professional or governmental guidelines. Given the
length of the storage period for these samples, extensive
retrospective analyses with significant periods of clinico-
pathological follow-up for patient studies can be carried
out.
Embedding of samples in paraffin after formalin fixa-
tion is a standard of practice [7]. This poses a problem for
gene expression studies, because formalin fixation and
the subsequent ethanol processing results in the forma-
tion of cross-links between RNA molecules and proteins,
leading to a significant reduction in recovery of RNA
from FFPE tissue. Formalin fixation and ethanol process-
ing also leads to the production of mono-methylol and
ethoxylated adducts with the bases of nucleic acids, as
well as depurination fragments [8-10], reducing the effi-
ciency of reverse transcription and negatively affecting
downstream applications [7].
Despite these challenges, extraction of miRs from FFPE
tissue is possible, as the small size contributes to their sta-
bility during fixation and processing [11]. miRs may also
be protein protected by the RISC complex and therefore
less susceptible to RNA degradation in comparison to
mRNAs [12], however they do not totally escape degrada-
tion even in fresh-frozen tissues [13]. Despite this, miRs
are more stable and more easily recovered from FFPE tis-
sue than mRNAs [7], and may be a better choice for
expression profiling when using FFPE samples [7,11].
Previously it has been shown that regardless of fixation
time or age of tissue blocks, quantitative real-time PCR
data for two miRs (miR-16 and miR-122) can be gener-
ated from FFPE tissues from different sites [14]. Although
other studies have shown miR expression analysis using
FFPE samples [11,12,14-20], to date, only one other study
has shown the utility of the TaqMan Low Density Array
technology for high-throughput miR expression profiling
in archival and paired fresh-frozen tissue [21]. Here we
demonstrate the use of quantitative real-time PCR (qRT-
PCR) in high-throughput analysis of miR expression for
365 miRs using the TaqMan Low Density Array technol-
ogy in clinical FFPE samples. We examine the utility of
the TaqMan Human MicroRNA Array v1.0 (Early Access)
microfluidics platform (Applied Biosystems) in the study
of miR expression, and demonstrate the optimization
steps needed to carry out an experiment using this plat-
form. Comparison of high-throughput analysis of miR
expression using FFPE samples and paired fresh-frozen
samples is also shown. This may be of use to many
researchers, due to the availability of archival samples in
pathology laboratories worldwide.
Results
Optimizing input RNA concentration for TaqMan Human 
MicroRNA Array
RNA from a FFPE benign, reactive lymph node was
reverse transcribed and the resultant cDNA applied to
the TaqMan array. Varying RNA concentrations (10, 25,
50, 100 and 200 ng/μL) were used to assess the sensitivity
of the TaqMan array platform to detect small quantities
of RNA. All reverse transcription reaction products were
diluted 15× prior to adding TaqMan 2× Universal PCR
Master Mix, No AmpErase UNG and undergoing qRT-
PCR. Duplicate plates were run to examine the reproduc-
ibility of the method. Ct values were determined for each
individual miR for each sample. The Pearson correlation
coefficients for each pair of samples were: 0.92 (10 and 25
ng/μL), 0.94 (50 and 100 ng/μL) and 0.95 (200 ng/μL).
cDNA dilution factors in this analysis were kept constant
at 15× for each plate.
Mixed model regression analysis was applied in order
to adjust for repeated measures of the same sample and
potential dilution effects. Using this analysis, the adjusted
Pearson correlation coefficient was 0.95 (p < 0.00001).
These results showed that RNA from FFPE tissues can be
reliably amplified by qRT-PCR, and the quantification
measures are reproducible between duplicates. The cor-
relation coefficients obtained between duplicate pairs of
input RNA amounts were high, ranging from 0.92 to 0.95,
increasing with higher RNA concentrations.
In qRT-PCR, accurate and reproducible data are depen-
dent on the Ct value. Low Ct values indicate the presence
of higher template abundance, and are usually associated
with a higher reproducibility and lower variability [22].
We thus stratified our data based on Ct values and
divided miRs into three strata of high (Ct values <30),
medium (Ct values from 30-35) and low abundance (Ct
values >35). To establish these cutoffs for miR abundance,
we plotted the absolute value of the difference between
duplicate Ct measurements as a function of the duplicate
mean, for all input RNA concentrations. Measurements
where one or both of the duplicate Ct values are exactly
40 are removed. Using the R statistics package (R Devel-
opment Core Team, 2008), we applied a cubic spline
function to fit a smooth curve to the data (Additional file
1, Figure S1). miRs with Ct values <30 showed the least
v a r i a b i l i t y .  I n  c o n t r a s t ,  m i R s  w i t h  C t  v a l u e s  > 3 5  w e r e
highly variable. We examined how the various RNA con-
centrations affected miR abundance and Ct reproducibil-
ity in each stratum. As seen in Figure 1, the high
abundance stratum is associated with consistently high
reproducibility between biological and technical repli-
cates. Reproducibility decreases across the medium stra-
tum, and is consistently poor in the low stratum. Results
from this analysis also demonstrated a shift in the num-Goswami et al. BMC Biotechnology 2010, 10:47
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ber of miRs from the low and medium abundance strata
to the high abundance stratum with increasing concen-
trations of input RNA (Figure 1A).
Boxplots outlining the summary statistics for the differ-
ence in Ct values between duplicate plates at each input
RNA concentration were developed to determine which
input RNA concentration has the least variation between
duplicate plates (Figure 1B). From this analysis, the vari-
ability between duplicate plates decreases from the low to
the medium and high abundance strata. In addition, this
analysis reveals that an input RNA concentration should
be maximized wherever possible to improve technical
reproducibility.
Assessing well failures at varying input RNA concentrations 
and cDNA dilutions
In order to assess the amplification efficiency when using
this TaqMan array platform, we counted the number of
wells that did not amplify in the plates (defined as well
failures). Since the qRT-PCR reactions were set up to run
for 40 cycles, a well was marked as a "failure" when, for
the same miR, a Ct = 40 was recorded for one plate and a
Ct < 40 was recorded for the duplicate. When both wells
had a Ct = 40, Ct values for that miR were compared to
the Ct values obtained at other concentrations, for the
same sample, and also compared to the positive control,
Universal RNA. If Ct values < 40 were obtained at other
concentrations or on the plates containing Universal
RNA for that miR, both wells were deemed to be "fail-
ures". The total number of well failures were assessed, for
each plate, at each RNA concentration, and averaged
among duplicate plates. The percentage of well failures
was calculated as follows: Average percentage of well fail-
ures = Average well failure between duplicate plates/
Number of miRs expressed*100 (Additional file 2, Figure
S2). The percentage of well failures decreases with
increasing input RNA concentration (Additional file 2,
Figure S2). From these results, the lowest percent well
Figure 1 Ct values according to different input RNA concentrations. A) Plot of the difference in Ct values vs. mean Ct between duplicate plates 
for varying input RNA concentrations. Red lines indicate divisions between high (Ct<30), medium (30≤Ct≤35) and low (Ct>35) abundance strata. The 
total number of miRs is shown within each stratum for each RNA concentration (e.g., 72 miRs have Ct values <30 at the 10 ng RNA dilution compared 
to 112 miRs at the 200 ng dilution). B) Boxplots depicting the median of the absolute difference in Cts between duplicate plates for each miR abun-
dance stratum according to input RNA concentration.
A) B)Goswami et al. BMC Biotechnology 2010, 10:47
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failure (<5%) is seen with the highest input RNA concen-
tration (200 ng/μL).
We also wanted to observe the effect of changing the
cDNA dilution on well failures. For this experiment,
input RNA concentrations were held constant at 200 ng/
μL and 100 ng/μL. After reverse transcription at these
input RNA concentrations, cDNA samples were diluted
at 62.5× (as outlined by the manufacturer's protocol),
30×, and 15×, respectively. Well failures were assessed as
previously outlined. Since we observed high correlation
coefficients in the previous experiments, demonstrating
robustness of the platform, only one plate per cDNA dilu-
tion was run to assess well failure. In this case, we define a
well failure when a Ct value of 40 was obtained for any
given miR known to be expressed in that same sample.
Our analysis showed that the percentage of well failures
increases with cDNA dilution, and well failures are higher
with lower input RNA concentration at the same cDNA
dilution factor (Additional file 2, Figure S2). From these
results, we conclude that the optimal input RNA concen-
tration is 200 ng/μL, with a 15× cDNA dilution.
Determining the optimal amount of RNA input 
concentration and cDNA dilution
Given the results above, we wanted to determine whether
miR expression would be the same for equivalent input
RNA concentrations and cDNA dilutions, defined here as
equivalent samples. We tested the following RNA input
and cDNA dilutions: 200 ng/μL at a 15× cDNA dilution,
100 ng/μL at a 7.5× cDNA dilution and 66.7 ng/μL at a 5×
cDNA dilution. The Pearson correlation coefficient
between these samples was > 0.944 (Range: 0.944-0.96)
and the percentage of well failures (assessed as described
earlier) between the samples was similar, ranging from 4-
7% (Additional file 3, Table S1).
We also investigated the concordance in miR expres-
sion between equivalent samples. In this analysis, we
compared the 200 ng/μL input RNA at 15× cDNA dilu-
tion with its duplicate and with the 100 ng/uL RNA at
7.5× cDNA dilution and 66.7 ng/uL RNA at 5× cDNA
d i l u t i o n .  W e  s t r a t i f i e d  e a c h  m i R  b y  i t s  m e a n  C t  v a l u e
across these conditions, and determined the correlation
between these conditions in each stratum (low, medium
and high abundance).
The concordance rate was highly dependent on tran-
script abundance, as seen in the correlation heat-maps
produced from these data (Figures 2A-C). We found a
similar correlation between equivalent samples, with no
statistically significant differences among the pair-wise
correlations. As would be expected for equivalent sam-
ples, there were no significant differences in the distribu-
tion of miRs among the abundance strata by the chi-
square test (χ2 = 3.3, df = 6, p = 0.77) (Additional file 4,
Table S2).
Comparison between fresh-frozen and FFPE clinical 
samples
Pearson correlation coefficients were calculated for 3
tumour samples and 3 benign lymph nodes, according to
the different extraction methods used. High correlation
values of up to 0.87 (p < 0.0001; calculated based on an
asymptotic t-distribution) are seen when comparing
FFPE to fresh-frozen samples, regardless of extraction
method used, and a correlation of 0.92 (p < 0.0001) is
seen on comparison of fresh-frozen tissues extracted with
different methods. A comparison of the summary statis-
tics using mean Ct values obtained for each extraction
method between tumour and control samples was also
performed (Figure 3).
Unsupervised hierarchical clustering analysis was per-
formed (hclust R function, one minus Pearson correlation
distance measure) for tumours and normal samples, tak-
ing into account the extraction method used. Figures 4A-
C are heatmaps showing the results for the low, medium
and high abundance miRs. Principal component analysis
(PCA) was also applied, and confirmed that all tumours
group together and separate from normal samples, inde-
pendent of the tissue specimen and method used for
RNA extraction (Figure 4D).
Finally, the number of detectable miRs in each abun-
dance stratum was determined for FFPE compared to
fresh-frozen samples, using the results from all 3 normal
benign lymph nodes and all 3 mantle cell lymphoma sam-
ples (Table 1 and Figure 5A-C). From this analysis, we
detected a similar number of medium abundance miRs
regardless of tissue source and extraction method used.
Similar numbers of miRs are seen in all abundance strata
among fresh-frozen samples regardless of extraction
m e t h o d  u s e d ,  w h e r e a s  F F P E  s a m p l e s  t e n d  t o  h a v e  a n
increase in the number of low abundance miRs and a
decreased number of high abundance miRs. Chi-square
analysis demonstrates that the shift in proportion of miRs
in the three strata is significantly different between fresh-
frozen and FFPE tissues [TRIzol and FFPE (χ2 = 17.5, df =
2, p = 0.0002); mirVana and FFPE (χ2 = 13.5, df = 2, p =
0.001)], but not between TRIzol and mirVana (χ2 = 0.32,
df = 2, p = 0.85). This difference may be due to reduced
RNA yields in FFPE samples, which is known to occur
and has been reported in the literature [7-10].
Discussion
Recent studies have shown that miR expression profiling
may be more accurate for distinguishing disease states
than mRNA expression analysis [23,24]. Since miRs are
better preserved, and can be obtained from FFPE tissue,
they may be a better choice for expression studies when
using FFPE samples [11]. miR expression has been exam-
ined in FFPE and fresh-frozen tissue specimens. For
example, an 89% correlation in miR expression profilesGoswami et al. BMC Biotechnology 2010, 10:47
http://www.biomedcentral.com/1472-6750/10/47
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was shown between FFPE and fresh-frozen samples from
murine liver, using a locked nucleic acid (LNA)-based
miR microarray platform [11]. Other studies, using
human tissue sources (colon, myometrium, lymph node,
melanocytes), on various microarray platforms (mirVana
miRNA Bioarrays, Agilent human miRNA arrays, and
Invitrogen Ncode Multi-Species miRNA microarrays),
showed high correlation between miR expression profiles
in FFPE and fresh-frozen samples [18-20]. Technologies
such as Luminex's fluorescence labeled beads, when used
on FFPE and fresh-frozen breast tissue, also yielded simi-
lar results [15], showing that FFPE tissues are useful for
miR expression analysis.
Another platform for miR expression analysis, using
high-throughput qRT-PCR, has yielded high correlation
coefficients when comparing fresh-frozen and FFPE sam-
ples [12,16,17]. Recently, a comparison between FFPE
and fresh-frozen tissue using two pairs of breast carci-
noma samples was performed on the high-throughput
qRT-PCR TaqMan Human MicroRNA Array v1.0 (Early
Access), demonstrating a correlation of 0.94 between
paired samples [21]. In our study, we also tested the Taq-
Figure 2 Clustering heat-maps and pair-wise correlations for equivalent samples. The pair-wise correlations between equivalent samples are 
shown within A) low abundance stratum: The low abundance miRs have a low correlation coefficient (range: 0.16-0.31) regardless of the concentration 
and dilution factor used. B) medium abundance stratum, showing higher correlation coefficients (range: 0.75-0.86) compared to the low abundance 
stratum. C) high abundance stratum: In this stratum we detect the highest correlation coefficients (range: 0.98-0.99) between samples. Note that the 
scales are different for each abundance stratum, reflecting the respective correlation coefficients.Goswami et al. BMC Biotechnology 2010, 10:47
http://www.biomedcentral.com/1472-6750/10/47
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Man Human MicroRNA Array v1.0 (Early Access) plat-
form to show its utility and reproducibility in
determining a miR expression profile using FFPE clinical
samples. However, our study differs in several aspects,
including the assessment of different extraction methods
and demonstration of platform optimization using less
than recommended RNA amounts as described in Mate-
rials and Methods. These experiments are necessary to
warrant the use of this platform in the study of miR
expression in FFPE tissues, and have not been previously
described. Our study also adds new information to the
current literature, showing the importance of stratifying
miRs based on abundance when analyzing miR expres-
sion data.
Our optimization results showed that the amount of
input RNA and dilution of the cDNA can affect miR
expression levels detected. These effects are more pro-
nounced if examined from the perspective of miR abun-
dance. Our results show that input RNA from FFPE
samples should be maximized and that dilution of cDNA
should be kept to a minimum, in order to generate the
most reliable and reproducible miR expression profiles
using the TaqMan Human MicroRNA Array v1.0 (Early
Access) platform. This is apparent when observing the
shifts that occur in miR abundance with changes in RNA
input concentration. As seen in Figure 1A, with a lower
input RNA concentration, a lower number of high abun-
dance miRs are detected. Our results showed a significant
shift in the proportion of miRs in each abundance stra-
tum with the increase in input RNA concentration from
10 ng/μL to 200 ng/μL (chi-square test, χ2 = 12.7, df = 2, p
= 0.002). The largest change is decreasing frequency of
low abundance miRs (163 to 130) and increasing fre-
quency of high abundance miRs (72 to 112), a pattern
which is consistent over each increment of input RNA
concentration. Of note, the low abundance strata across
the input RNA concentrations have a higher variability,
compared to the medium and high abundance strata at
the same concentrations, as shown in Figure 1B. This
demonstrates that expression values obtained for miRs
within the medium and high abundance strata are more
reliable for analysis and a direct link between increasing
input RNA concentration and improved reliability for low
and medium abundance miRs.
Well failures are also less common as input RNA con-
centrations increase or cDNA dilutions decrease. Inter-
Figure 3 Ct values according to different extraction methods for paired fresh-frozen and FFPE tissues. Comparison of the summary statistics 
(mean Ct, standard deviation, and overall range of Ct values) using raw Ct scores obtained from the normal lymph nodes and mantle cell lymphoma 
samples extracted using three separate RNA extraction methods. On comparison of the FFPE summary statistics to those from the mirVana and TRIzol-
Qiagen extraction protocols, we see that the mean Ct values obtained from the FFPE samples are significantly higher than those obtained from the 
mirVana and TRIzol-Qiagen extraction protocols (p < 0.0001 and p < 0.0001 respectively).
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Figure 4 Correlation heatmaps and PCA mapping for paired fresh-frozen and FFPE tissues. Correlation heat-maps demonstrating hierarchical 
clustering among 3 normal lymph nodes (n1-n3) and 3 mantle cell lymphomas (t1-t3) extracted using different techniques using: A) Low abundance 
miRs B) Medium abundance miRs C) High abundance miRs. Panel D) shows principal component analysis (PCA) confirming the similarity of miR ex-
pression between tumours (red), and normal samples (blue), irrespective of tissue origin (FFPE vs. fresh-frozen).
Table 1: Numbers of miRs in each abundance stratum according to different extraction methods used.
Extraction method
RecoverAll protocol
(FFPE)
mir Vana protocol
(Fresh-frozen tissue)
TRIzol-Qiagen
(Fresh-frozen tissue)
Low 125 96 90
Medium 141 122 122
High 118 166 172Goswami et al. BMC Biotechnology 2010, 10:47
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estingly, dilution of cDNA can be used in order to
compensate for low input RNA amounts, a scenario
which can occur should RNA yield be low. This can be
observed when comparing an input RNA concentration
of 200 ng/μL with a 15× cDNA dilution factor and an
input RNA concentration of 66.7 ng/μL with a 5× cDNA
dilution factor. Our results show the consistency of Ct
values obtained with different cDNA dilution factors
(Pearson correlation 0.95). This was also shown to be true
when examining correlation coefficients relative to miR
abundance. There was also no statistically significant
shift in the proportion of miRs in each abundance stra-
tum between equivalent combinations of input RNA con-
centration and cDNA dilution [chi-square test, (χ2 = 3.3,
df = 6, p = 0.77)]. In our laboratory, we have optimized
the experiments to use an input RNA concentration of
200 ng/μL with a 15× cDNA dilution factor. This gives us
the flexibility to use input RNA concentrations as low as
Figure 5 Comparison of miR abundance in paired fresh-frozen and FFPE tissues, using different RNA extraction methods. Plots show the 
comparison of Ct values for three normal and three mantle cell lymphoma samples by the three different extraction methods: A) FFPE (RecoverAll) vs. 
mirVana; B) FFPE (RecoverAll) vs. TRIzol; C) TRIzol vs. mirVana. Red lines delineate the abundance strata for each extraction method, with numbers in-
dicating the average number of miRs per sample in each zone. For example, in the FFPE vs. mirVana plot (Figure 5A), 44 miRs are high abundance by 
mirVana and medium abundance by FFPE (RecoverAll), but only 4 miRs are high abundance by FFPE (RecoverAll) and medium abundance by mirVana.
A) B)Goswami et al. BMC Biotechnology 2010, 10:47
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60 ng/μL with a 5× cDNA dilution factor, which is the
lowest cDNA dilution possible according to the manufac-
turer's protocol, in order to maintain equivalent miR pro-
files between samples.
Finally, we showed that miR expression was highly cor-
related in FFPE and fresh-frozen lymphoid tissues,
regardless of the extraction method used, despite the fact
that raw Ct scores obtained from FFPE samples are signif-
icantly different than those from fresh-frozen tissue. This
is likely due to reduced yields of RNA from FFPE tissue.
Unsupervised hierarchical clustering analysis, using cor-
r e l a t i o n  h e a t - m a p s ,  s h o w e d  t h a t  t u m o u r  a n d  n o r m a l
samples clustered in separate groups. The hierarchical
clustering performed according to miR abundance dem-
onstrated that the medium abundance miRs appear to be
most informative in helping to segregate tumours from
normal samples. This may be because many miRs that fall
into the low abundance category are potentially not
expressed in lymphoid tissue. Our pre-filtering removed
miRs with Ct values of 40 in all twelve samples, meaning
that if one miR had a Ct value less than 40 but greater
than 35 in even one sample, it would be included in the
analysis as a low abundance miR. The high abundance
miRs may be informative as well, although one tumour
sample clusters together with the normal samples. Inter-
estingly, this tumour is a post-treatment sample; the
patient having been treated with R-CHOP (rituximab-
cyclophosphamide-doxorubicin-vincristine-prednisone)
prior to biopsy and sample collection. Rituximab is an
anti-CD-20 antibody, which targets B-lymphocytes
expressing CD20 (including mantle cell lymphoma), and
combined with CHOP chemotherapy, it has been shown
to improve overall and complete response rates, as well as
time to treatment failure, in mantle cell lymphoma
patients [25,26].
Also of note is the shift of miRs from high to medium
and medium to low abundance in FFPE compared to
fresh-frozen tissue, seen in Table 1 and Figure 4. The shift
in proportion of miRs in the three strata is significantly
different by chi-square test between TRIzol and FFPE (χ2
= 17.5, df = 2, p = 0.0002) and between mirVana and FFPE
(χ2 = 13.5, df = 2, p = 0.001), but not between TRIzol and
mirVana (χ2 = 0.32, df = 2, p = 0.85). This decrease in the
proportion of high abundance miRs and increase in the
proportion of low abundance miRs may be due to known
reduction of RNA yields that occur in FFPE tissue [7-10].
Reduction in RNA yield is seen due to chemical modifica-
tion of RNA introduced by formalin fixation. This modi-
fication occurs through the addition of mono-methylol (-
CH2OH) groups to RNA, as well as formation of second-
ary modifications such as methylene bridging, preferen-
t i a l l y  a t  a d e n i n e  r e s i d u e s  [ 8 ] .  A l t h o u g h  m i R s  m a y  b e
relatively protected due to association with other proteins
(e.g. the RISC complex), some modifications likely occur
since the shift in miR abundance from high to medium
and from medium to low indicates a reduction in miR
yield from FFPE samples. This effect has also been seen
by Hoefig et al. [16] who demonstrated a 1.0-1.5 Ct
reduction in miR expression between fresh-frozen tissues
and their paired FFPE samples. In our study we observe
that this reduction does not affect sample biology. Our
PCA results (Fig. 4D) reveal a complete separation
between normals and tumours regardless of sample treat-
ment (FFPE vs. fresh-frozen). Similar to our results, Hoe-
fig et al. [16] demonstrated that biologically relevant miR
expression profiles between liver and lymph node tissues
were unchanged regardless of tissue treatment, and that
this biological variance was higher than the technical
variance introduced by formalin fixation and paraffin
embedding [16]. In our study, by comparing normal and
tumoural tissues from the same source (lymphoid), we
were able to demonstrate robust differential expression,
which was higher than the differences between FFPE and
fresh-frozen tissue, as seen in Figure 4. Thus, the correla-
tions reported in our study demonstrate that miR levels
likely reflect the disease state in patients regardless of tis-
sue source (FFPE vs. fresh-frozen) used for analysis.
Although our results show that the technical differ-
ences introduced by tissue treatment are minimal, we
also show that data analysis can be strengthened by
examining miR expression according to abundance strata.
As seen in Figure 4, our results indicate that stratification
o f  m i Rs  a c c o r d i n g  t o  a b u n da n c e  s h o u l d  be  c o n s i d e r ed
during data analysis as low abundance miRs (Ct>35) do
reveal low correlation coefficients when compared to
medium (30≤Ct≤35) and high abundance miRs (Ct<30).
Based on our results, we would exclude the low abun-
dance miRs from analysis as the miRs in the medium and
high abundance strata show superior correlations and
sample clustering. We suggest that investigators stratify
their miR expression data and judge whether or not to
i n c l u d e  m i Rs  fr o m  a l l  s t r a t a  d u ri n g  da t a  a n a l ys is  o n  a
c a s e - b y - c a s e  b a s i s .  T h i s  m e t h o d  o f  d a t a  a n a l y s i s  s u g -
gested by us is a potential tool for further optimization of
miR expression data derived from FFPE samples and will
increase the correlation between these samples and their
paired fresh-frozen tissues.
Conclusions
Overall, our study demonstrates the utility of the high-
throughput, qRT-PCR-based platform for miR expression
using FFPE clinical samples. The expression profiles
obtained from the arrays are reproducible, demonstrating
high correlation values both within the same samples and
between samples. Expression profiles generated through
this high-throughput method can be used to discern
between different disease states (benign and malignant).
Of note, RNA input concentrations used on this platformGoswami et al. BMC Biotechnology 2010, 10:47
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should be maximized whenever possible, and cDNA dilu-
tion factors should be kept to a minimum.
Given the availability of FFPE samples in laboratories
worldwide, and the amenability of array platforms for the
use of FFPE samples, we believe that optimization and
use of high-throughput analysis, such as miR expression
will facilitate further insight into disease biology.
Methods
Samples
Samples were collected at surgical resection and ranged
from 1 to 8 years in age. Samples were divided into two
specimens at collection: one used for formalin fixation
and paraffin embedding, the other placed in Optimal
Cutting Temperature (OCT) compound and stored in liq-
uid nitrogen until RNA extraction. FFPE samples from
four benign, reactive lymph nodes and three mantle cell
lymphomas were obtained from the Department of
Pathology at the University Health Network with the
approval of the Research Ethics Board. Three to five 10
μm sections were obtained and kept under RNase-free
conditions until RNA extraction. Paired fresh-frozen and
FFPE samples (3 benign reactive lymph nodes and 3 man-
tle cell lymphomas) were used for comparison. Mantle
cell lymphoma samples contained >80% tumour cells in
all sections. One case (t1) was a post-treatment sample.
In addition, Universal RNA (Stratagene), which is a
pooled RNA from 10 cancer cell lines, was used as a posi-
tive amplification control.
RNA extraction
RNA from FFPE samples was extracted using the Recov-
erAll Total Nucleic Acid Isolation Kit (Ambion), as it has
been shown to be the preferred RNA extraction method
for FFPE samples [7]. Modifications to the manufacturers'
protocol were carried out as follows in order to improve
RNA yield: 1 mL of xylene was added to each sample and
the mixture heated at 50°C for 5 minutes to melt the par-
affin. The samples were centrifuged at maximum speed
twice for 2 minutes each to pellet the sample. The xylene
was removed and samples were washed twice in 100%
ethanol with centrifugation at 12,000 rpm. The pellet was
dried at 37°C for 10-15 minutes prior to addition of 400
μL of Digestion Buffer and 8 μL of Protease provided in
the kit. The samples were then incubated at 50°C over-
night in order to obtain complete digestion of the sam-
ples. The remainder of the protocol was carried out as
per manufacturer's instructions with the exception of the
elution step in which the samples were eluted in a total of
30 μL RNase-free water (Sigma) instead of the recom-
mended 60 μL.
RNA from the fresh-frozen samples was obtained using
two different extraction methods. We wished to examine
whether or not our in-house RNA extraction method
(TRIzol followed by Qiagen purification) would yield
similar results to the commercially available mirVana
Total RNA Isolation kit as used by Doleshal et al. 2008.
Samples were ground with the use of liquid nitrogen and
a mortar and pestle. Half of each sample was placed in
either 300 μL of Lysis Buffer (mirVana Total RNA Isola-
tion Procedure protocol; Ambion) or 1 mL TRIzol (Invit-
rogen). The samples were then homogenized using a
mortar and pestle. RNA extraction using the mirVana
Total RNA Isolation Procedure was performed as per
manufacturer's instructions. The TRIzol extraction pro-
tocol was carried out by incubating the sample in TRIzol
reagent at RT for 5 minutes, followed by addition of 200
μL of chloroform to, the mixture, which was shaken vig-
orously for 15 seconds, incubated at RT for 3 minutes,
and centrifuged at 12,000 × g at 4°C for 15 minutes. The
upper aqueous phase was then removed, transferred to a
fresh tube, and 500 μL of isopropyl alcohol was added.
The mixture was then incubated at -20°C for 15 minutes
prior to placing it on an RNeasy spin column (Qiagen).
The remainder of the protocol was carried out using the
instructions provided with the RNeasy Mini kit (Qiagen),
with the exception of the elution step, which used a total
volume of 40 μL RNase-free water (Sigma). The concen-
tration and purity of all RNA samples were assessed using
the NanoDrop spectrophotometer (NanoDrop Technolo-
gies Inc.).
Generation of miR expression data using the TaqMan 
Human MicroRNA Array
Generation of miR expression data was a two-step pro-
cess involving a reverse transcription reaction followed
by a quantitative real-time polymerase chain reaction
(qRT-PCR). The reverse transcription reaction was car-
ried out according to the manufacturer's instructions
including 1 mM dNTPs (including TTP), 50 U Multi-
Scribe Reverse Transcriptase, 3.8 U RNase inhibitor, and
1× Reverse Transcription buffer. The manufacturer sug-
gests the use of 10-100 ng/μL of input RNA for each
reverse transcription reaction. TaqMan stem-loop prim-
ers for 365 individual miRs and 3 endogenous controls
were used in the reverse transcription reaction. Condi-
tions for the reverse transcription reaction were as fol-
lows: 16°C for 30 minutes, 42°C for 30 minutes, 85°C for 5
minutes, then hold at 4°C. cDNA samples were stored at -
20°C overnight prior to application on the TaqMan
Human MicroRNA Array v1.0 (Early Access). The Taq-
Man Human MicroRNA Array v1.0 (Early Access) [Taq-
Man array] is a 384-well microfluidics card containing
365 primer-probe sets for individual miRs as well as
duplicates of 3 primer-probe sets for endogenous small
nucleolar RNAs and duplicate negative control blank
wells. Reverse transcription reaction products were
diluted (62.5×, 30×, 15×, or 5×) prior to adding an equiva-Goswami et al. BMC Biotechnology 2010, 10:47
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lent volume of T aqMan 2× Universal PCR Master Mix,
No AmpErase UNG. A minimum of 5× cDNA dilution is
required to obtain the necessary volume for application
to the TaqMan Human MicroRNA Array. The entire mix-
ture was then added to individual ports of the TaqMan
Human MicroRNA Array v1.0 (Early Access); the array
was centrifuged at 1,200 rpm twice for 1 minute each, and
then run on an Applied Biosystems 7900HT Fast Real-
Time PCR system for 40 cycles. Raw microRNA data
(GEO series record GSE22264) are available for download
at http://www.ncbi.nlm.nih.gov/geo/.
Statistical and bioinformatics analysis
Mixed model regression analysis was used to adjust for
repeated measures of the same sample and the potential
dilution effects. This, as well as bar plots, were generated
using SAS software, Version 9.1 of the SAS System, Copy-
right  ©2009 SAS Institute Inc. SAS and all other SAS
Institute Inc. product or service names are registered
trademarks or trademarks of SAS Institute Inc., Cary,
NC, USA [27]. 3-D principal component analysis (PCA)
was performed using Partek® software, version 6.4 Copy-
right © 2009 Partek Inc., St. Louis, MO, USA [28].
All other statistical analysis and plotting were per-
formed using the R statistical environment (R Develop-
ment Core Team, 2008, v2.8.1) [29], on the IBM HS21XM
BladeCentre cluster running CentOS 5.1. Additional plot-
ting functions were used from the fields (v.5.0.2) [30] and
RColorBrewer (v1.0-2) [31], R packages.
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